ANG Lifesciences India Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from ANG Lifesciences India Ltd. on BSE

Load latest

ANG Lifesciences India Ltd.

13 Jun 2024

30.67

-1.98%

Company Update

ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Reg 30 & 47 of SEBI(LODR) Regulations, 2015, enclosed are the copies of Newspaper advertisements of Audited Financial Results of quarter and year ended at 31.03.2024.

pdf

ANG Lifesciences India Ltd.

13 Jun 2024

30.67

-1.98%

Company Update

ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Cessation

BSE India

Resignation of Mr. Pawanjit Singh w.e.f 28.05.2024 due to completion of his tenure.

pdf

ANG Lifesciences India Ltd.

03 Jun 2024

30.67

-1.98%

Annual Report

Annual report for ANG Lifesciences India Ltd. for FY-2024

None

pdf

ANG Lifesciences India Ltd.

30 May 2024, 08:51PM

30.67

-1.98%

Company Update

ANG Lifesciences India Ltd - 540694 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Annual Secretarial Compliance Report for FY 2023-24

pdf

ANG Lifesciences India Ltd.

30 May 2024, 06:52PM

30.67

-1.98%

Result

ANG Lifesciences India Ltd - 540694 - Financial Result For Quarter And Year Ended As At …

BSE India

Financial Result (Standalone & Consolidated) for quarter and year ended as at 31.03.2024

pdf

ANG Lifesciences India Ltd.

30 May 2024, 06:43PM

30.67

-1.98%

Board Meeting

ANG Lifesciences India Ltd - 540694 - Board Meeting Outcome for Outcome Of Board Meeting

BSE India

Considered and approved the Audited Standalone and Consolidated Financial Results for the Quarter and Financial Year ended 31st March, 2024. The said Audited Financial Results were reviewed by Audit Committee and thereafter approved by the Board of Directors.

pdf

ANG Lifesciences India Ltd.

27 May 2024

30.67

-1.98%

Company Update

ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Meeting Updates

BSE India

In pursuant to Reg. 30 of SEBI LODR, 2015, The Board of Directors of the company appointed Mr. Harvinder Singh as an Additional Director in the capacity of Independent Director w.e.f. 27.05.2024

pdf

ANG Lifesciences India Ltd.

24 May 2024

30.67

-1.98%

Board Meeting

ANG Lifesciences India Ltd - 540694 - Board Meeting Intimation for Approval Of Audited Financial Standalone …

BSE India

ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve 1. The Standalone and Consolidated Audited Financial Results of the Company for the quarter and year ended 31st March, 2024. 2. Any other business that may be necessary with the permission of Chairman.

pdf

ANG Lifesciences India Ltd.

13 May 2024

30.67

-1.98%

Company Update

ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Meeting Updates

BSE India

As per regulation 30 (read with Part A of Schedule III) and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Mrs. Saruchi Gupta has been appointed as Chief Financial Officer of the company on the recommendation of Nomination and Remuneration Committee.

pdf

ANG Lifesciences India Ltd.

30 Apr 2024, 04:35PM

30.67

-1.98%

Company Update

ANG Lifesciences India Ltd - 540694 - Disclosure And Intimation Of Non-Applicability Of SEBI Circular No …

BSE India

We hereby confirm that ANG Lifesciences India Limited is not falling under Large Corporate category as on 31st March, 2024

pdf

Is ANG Lifesciences India Ltd. worth buying?

61 Votes:

Buy 77.05%

Sell 11.48%

Hold 11.48%